1Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction and prevention[J]. Am J Med , 1993,95(3): 315.
2Levine M, Raskob GE, Landefeld CS, et al. Hemorrhagic complications of anticoagulant treatment[J]. Chest, 1995,108(4 Suppl) :276s.
3Errichtti AM, Holden A, Ansell J. Management of oral anticoagulation therapy-experience with an anticoagulation clinic[J]. Arch Intem Med, 1984,144(10) : 1966.
4Wilt VM, Gums JG, Ahmed OI, et al. Outcome analysis of a pharmacist-martaged anticoagulation service [J]. Pharmacotherapy , 1995, 15 (6) :732.
5Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost justification of a clinic.,d pharmacist managed anticoagulation clinic [ J ]. Drug Intell Pharm, 1985,19(7) :575.
6Wesson T, Randall GE, Barrows D,e! al. Improved organization performance through the interdisciplinary provision of services: a case study of an economic evaluation of pharmacist dosing of warfarin[ J ]. innovation J: Public Sector Innovation J, 2006,11 ( 1 ) : 1.
7Calcagno Jr. D, Pubentz M, Carey R. Improving patient satisfaction with warfarin management[J]. Am J Man Care, 1996,2(7) :804.
8Phillips KW, Wittkowsky AK. Survey of phannacist-managed inpatient anticoagulation services[J], Am J Heahh-Syst Pharm ,2007,64(21): 2275.
9Dager WE, Gulseth MP. Implementing anticoagulation management by pharmacists in the inpatient setting[J]. Am J Health-Syst Phann ,2007, 64(10):1071.
10Pubcntz MJ, Calcagno DE Jr, Teeters JL. Improving warfarin anticoagulation therapy in a commun/ty health systera [ J ]. Pharm Pract Manag Q, 1998,18(3) : 1.
